FindTrial
Sign In

The role of HDAC6 of the development of peritoneal fibrosis in peritoneal dialysis patients.

The role of HDAC6 of the development of peritoneal fibrosis in peritoneal dialysis patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014672
Enrollment
Unknown
Registered
2018-01-28
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritonitis

Interventions

Case series:regular peritoneal dialysis

Sponsors

Shanghai East Hospital Affiliated to Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Having uremia and conducting regular peritoneal dialysis in our hospital; 2. conducting The peritoneal dialysis for about 3~24 months.

Exclusion criteria

Exclusion criteria: Having peritonitis, severe heart failure, unstable angina, active liver disease, trauma, surgery, etc in the last month.

Design outcomes

Primary

MeasureTime frame
HDAC6;—

Countries

China

Contacts

Public ContactNa Liu

Shanghai East Hospital Affiliated to Tongji University

naliubrown@163.com+86 18217768587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026